Therapeutic Application of Empagliflozin, Sitagliptin, and Metformin for Advancing Overall Wellness in T2D: Evidence Review for Practitioners in 2025 Dr. Manoj Chadha19 Feb 2026 10:35 AM ISTHyperglycemia in T2D plays a pivotal role in diabetic microvascular complications; however, reducing HbA1c offers only modest benefit in mitigating...
Understanding Chest Acne with Dermatologist Dr Radhika Kopikar Kamakshi18 Feb 2026 12:00 PM ISTAcne doesn't always play by the rules. In this video, dermatologist Dr Radhika Kopikar explains why chest acne occurs and how to effectively manage...
Aspirin Benefit for Primary Prevention in High-Risk T2D - Observational Analysis: AHA 2025 Abstract Dr. Nitin Gudage17 Feb 2026 12:00 PM ISTFor years, the medical community has sought the ideal balance for aspirin in primary prevention. New evidence from the American Heart Association...
Beta-Blockers Cut Cardiovascular Events by 25% in Post-MI Patients with Mildly Reduced LVEF: Meta-Analysis Prem Aggarwal16 Feb 2026 12:01 PM ISTLong-term oral Beta-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new...
Lifestyle-Linked CV Risk: Where Does Aspirin Fit? Dr. Nishant Tripathy13 Feb 2026 12:45 PM ISTIndia faces a rapidly evolving cardiometabolic risk landscape, with overweight and obesity affecting 23.5% and 6.7% of adults, alongside escalating...
Redefining Diabetes Management With Dapagliflozin and Sitagliptin FDC: An Early, Effective and Sustainable Option For T2D Management With Risk Factors Dr. Vaishali Deskhmukh12 Feb 2026 12:40 PM ISTType 2 diabetes in Indians follows a distinct and more aggressive trajectory, marked by higher insulin resistance, early Beta-cell dysfunction, lower...
Considering Triple Agents in Glucose Control - Application & Safety Considerations in 2026 Dr. Bhumika Maikhuri11 Feb 2026 11:00 AM ISTIn this episode of The Diabetes Wellness Forum, titled "Considering Triple Agents-Application & Safety Considerations in 2026," Dr Nandita Mohan...
Case Management of Chemotherapy Induced Anemia (CIA) with Darbepoetin Alfa in a Patient with Metastatic Breast Carcinoma - Dr Adwaita Gore Swapnil Sharma9 Feb 2026 10:45 AM ISTIn this video, Dr. Adwaita A. Gore, Medical Oncologist at S L Raheja Hospital, Mumbai, presents a real-world case highlighting the management of...
ROBUST Study Released: One of the Largest Beta-Blocker KAP Study Captures Place of Beta Blockers in Indian Real-World Practice Prem Aggarwal7 Feb 2026 12:08 PM ISTOne of the largest Indian KAP studies including doctors in cardiovascular medicine practice has shown that metoprolol continues to be the most...
Obesity-Prediabetes Duo: Why Clinicians Must Intervene Early? Dr. Siddhant Milind Dahale4 Feb 2026 12:30 PM ISTPrediabetes is alarmingly common, with the IDF 2025 Atlas estimating nearly 90 million Indians are affected. [1] Escalating obesity,...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
Efficacy and Safety of Dapagliflozin-Vildagliptin in Indian T2DM Patients with CV Risk Factors Dr. Bhumika Maikhuri30 Jan 2026 12:58 PM ISTThe Fixed-Dose Combination (FDC) of Dapagliflozin 5 mg + Vildagliptin 50 mg demonstrated significant improvements in Glycemic Control, Metabolic...
